Clinical Trial

Clinical Performance of High Viscosity Bioactive Injectable Composite in Deep Marginal Elevation

Study acronym: Randomized
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 13, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
Using a bioactive resin composite in subgingival Class II cavities can provide enhanced caries resistance by releasing multiple ions, including fluoride. This approach offers greater resistance to caries due to the incorporation of surface pre-reacted glass filler (S-PRG) technology (Imazato, Nakatsuka et al., 2023). This type of composite may improve the outcomes of deep subgingival margin elevation, benefiting both restorative success and periodontal health.
Trial Details
NCT Number NCT06875544
Lead Sponsor Future University in Egypt
Conditions DME, Dental, Deep Margin Elevation
Enrollment 50 participants
Start Date 2025-03
Primary Completion 2026-04 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-03-13